서영주 교수 연구실
article|
gold
·인용수 3
·2025
The effect of SGLT2 inhibitor in patients with type 2 diabetes and atrial fibrillation
Yongin Cho, Sung‐Hee Shin, Min-Ae Park, Young Ju Suh, Sojeong Park, Ji-Hun Jang, Dae-Young Kim, So Hun Kim
PLoS ONE
초록
In a nationwide cohort of patients with T2D and AF, SGLT2 inhibitor was associated with a lower risk of mortality, which may suggest that SGLT2 inhibitors may be considered as the first-line antidiabetic medication in patients with T2D and AF.
키워드
Atrial fibrillationType 2 diabetesMedicineDiabetes mellitusCardiologyInternal medicinePharmacologyEndocrinology